Clinical Evidence

Proven Efficacy Through Scientific Validation

Multi-Parameter Clinical Evaluation

Ostizeel™ has been clinically evaluated through multiple research studies to establish its effectiveness in addressing the multifactorial nature of osteoarthritis (OA). The formulation is designed to improve joint function, relieve pain, reduce inflammation, and protect cartilage integrity by targeting both nociceptive and neuropathic pathways.

Osteoarthritis is not a single-symptom disorder. It affects structural, neurological, and functional aspects of joint health. Ostizeel™ was assessed using standard global clinical evaluation tools, ensuring comprehensive measurement of its impact across multiple domains: WOMAC Score. VAS Score. LFI Score.

Pain Reduction

Significant reduction in joint pain was observed starting from Day 3, sustained over the treatment duration.

Enhanced Mobility

Increased joint range of motion, especially in knee flexion at 60°/s and 90°/s, reflecting improved mechanical function.

Cartilage Protection

Marked inhibition of cartilage-degrading enzymes (MMPs), leading to better joint structure preservation.

https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-6.jpg

Improvement in joint health

https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-1.jpg
WOMAC TOTAL Score
WOMAC Total Score
50 40 30 20 10 0
42.8
41.2
43.2

Baseline

32
27.7
25.4

Week 4

32
*
23.9
**
20

Week 8

https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-2.jpg
WOMAC Stiffness Score
WOMAC Stiffness Score
5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0
4.3
4.2
4.1

Baseline

3
2.7
2.2

Week 4

3.2
*
2.4
**
1.9

Week 8

https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-3.jpg
WOMAC Function Score
WOMAC Function Score
35 30 25 20 15 10 5 0
29.1
28.1
30.2

Baseline

22.1
19.3
17.6

Week 4

22.2
*
17.7
**
14.2

Week 8

https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-4.jpg
WOMAC Pain Score
7.4
4

Cucumber extract

6.9
5.2

Placebo

Week 0 Week 8
https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-6.jpg
Reduction in MMP-3
Reduction in MMP-3 (ng/mL)
14 12 10 8 6 4 2 0
*
13.03

Cucumber extract

2.2

Placebo

*p=0.018
https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-7.jpg
Reduction in IL-1β
% Reduction in IL-1β (pg/mL)
30 25 20 15 10 5 0 -5 -10 -15 -20
*
27.78

Cucumber extract

-14.29

Placebo

*p=0.004
https://ostizeel.com/wp-content/uploads/2025/07/ostizeel-Clinical-Evidence-5.jpg
Improvement in At 90° knee position
% Change compared to Placebo
Average power (W)
12.96 **
Relative peak torque (Nm/Kg)
14.74 *
Peak torque (Nm)
18.80 *
0 5 10 15 20

Safe. Effective. Clinically Verified.

The clinical benefits of Ostizeel™ go beyond pain relief — offering disease-modifying potential and long-term joint care. The consistent improvements observed across pain, stiffness, mobility, and inflammation parameters confirm its place as a next-generation solution in osteoarthritis management.